Although the results show a protective effect of Nrf2 against AD, Ramsey et al. reported that the level of Nrf2 is different according to brain location: usually this transcription factor is found in both nucleus and cytoplasm; however, in AD patients is primarily present in the cytoplasm [85]. Here, NFE2L2 is linked to Alzheimer disease.